Dialysis Access Treatment Devices – Market Insights – Europe

Expansion of the European dialysis access treatment device market will be driven by the growing ESRD population and increasing demand for maintenance devices. However, cost constraints may continue to limit widespread adoption in certain regions.

This Medtech 360 Report provides comprehensive data and analysis on the European dialysis access treatment device market from 2019 through 2034.

The outlook for the percutaneous AVF market remains uncertain.

How will BD’s sole presence in the European percutaneous AVF market impact competition and patient access following Medtronic’s exit?

To what extent could emerging percutaneous AVF technologies drive market expansion and improve clinical outcomes in Europe?

To what extent do physician training, institutional preferences, and entrenched clinical practices limit the uptake of percutaneous AVF technologies?

Growth in the dialysis access maintenance device market will be supported by rising procedure volumes and increased use of premium-priced devices.

How will growing clinical evidence affect the adoption of premium-priced dialysis access maintenance devices in Europe?

What impact will the launch of new DCB devices—and the entrance of new competitors—have on market dynamics over the coming years?

Budgetary constraints and limited reimbursement in certain segments continue to challenge the growth and adoption of advanced dialysis access treatment devices across Europe.

To what extent will insufficient reimbursement affect the adoption of premium-priced dialysis access devices?

Will reimbursement policies across European countries support or hinder the adoption of innovative technologies?

How will budgetary constraints shape clinical decision-making and influence market penetration of new products?